36
Publications
8.7K
Citations
13
H-Index
35
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 9 | 9 | 6K |
2 | Cell Biology | 4 | 4 | 255 |
3 | Health Sciences | 3 | 3 | 60 |
4 | Biochemistry | 1 | 1 | 115 |
5 | Biomedical Engineering | 1 | 1 | 13 |
Rut Porta
×
14
Publications
8.5K
Citations
13
H-Index
| Year | Citations | |
|---|---|---|
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial Rafael Rosell, Enric Carcereny, Radj Gervais, OncologyStandard ChemotherapyRandomised Phase 3PathologyBronchial Neoplasm | 2012 | 5.5K |
2009 | 2.4K | |
2017 | 182 | |
2007 | 115 | |
2006 | 114 | |
2007 | 64 | |
2016 | 51 | |
2014 | 31 | |
2014 | 28 | |
2013 | 16 |
Page 1
Page 1